C11.9
Malignant neoplasm of nasopharynx, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of nasopharyngeal wall NOS
Medical Intelligence & Overview
Malignant neoplasm of the nasopharynx, classified under ICD-10 code C11.9, refers to a type of cancer located in the nasopharynx—a part of the throat situated behind the nose. When the specific area within the nasopharynx is not precisely identified, it is described as 'unspecified.' This condition involves the uncontrolled growth of abnormal cells in this region, which can invade surrounding tissues and spread to other parts of the body. Recognizing and understanding this disease is essential for early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic predisposition, including family history of nasopharyngeal carcinoma Persistent infection with the Epstein-Barr virus (EBV) Environmental exposures such as inhaling dust or fumes containing carcinogens Dietary factors, including high consumption of salted, smoked, or preserved foods Smoking tobacco and excessive alcohol consumption Certain chemical exposures in occupational settings
Key Symptoms: Nasal congestion or blockage that persists Frequent nosebleeds Ear problems such as hearing loss, ringing, or discharge Facial pain or numbness A lump or mass in the neck due to lymph node involvement Persistent sore throat or sore that does not heal Difficulty speaking or swallowing
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on the head, neck, and throat Nasopharyngoscopy, a procedure using a thin, flexible tube with a camera to examine the nasopharynx Imaging tests like MRI, CT scans, or PET scans to identify tumor size and spread Biopsy, which involves collecting tissue samples for laboratory analysis to confirm malignancy Blood tests, including studies for Epstein-Barr virus antibodies, which may support the diagnosis
Treatment Protocols: Radiation therapy, which is often the primary treatment for this type of cancer Chemotherapy, used alone or in combination with radiation to target cancer cells Targeted therapy, which involves drugs designed to attack specific molecules involved in cancer growth Surgical intervention, although less common due to the location of the tumor, may be considered in certain cases Supportive care to manage symptoms and improve quality of life during and after treatment
Clinical Advice & FAQs
Billing Guidance
Is C11.9 a billable ICD-10 code?
Yes, C11.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C11.9?
Clinical documentation must specify the nature of Malignant neoplasm of nasopharynx, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference